AI-generated summary
In a study of scopolamine-treated rats, the authors report that photobiomodulation at 460 to 660 nm was associated with better memory test performance and preserved brain tissue structure compared with control groups. The authors also report changes in cholinesterase, oxidative stress and inflammatory markers, though the findings come from an animal model. The abstract does not provide clear limits on sample size or statistics.
- Who or what was studied
- Wistar male rats treated with scopolamine to induce memory impairment
- Wavelengths
- 460, 660 nm
- Limits stated in the abstract
- The study is in rats using a scopolamine-induced model, so results may not apply to human neurodegenerative disease.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 460-660 nm
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Photobiomodulation, Hormesis, Light-emitting diode, Reactive oxygen species, Oxidative stress, Inflammation, Dementia, Laser. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.